# Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer

> **NCT06654622** · — · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 175 (actual)

## Conditions studied

- Colo-rectal Cancer
- Colorectal Cancer Recurrent

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06654622
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-01
- **Primary completion:** 2026-01-18
- **Final completion:** 2026-02-18
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06654622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06654622, "Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06654622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*